Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals — GST demand of Rs. 16.05 crore on brand sale
REGULATORY
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 01 Apr 2026, 07:05 PM IST · BSE ID: 4da83983-f89c-4453-95a4-4851f63573e9
View Original BSE Filing (PDF)
💡
In Simple Terms
The GST tax department is claiming Glenmark owes Rs. 16.05 crore in unpaid taxes plus penalties on a 2021 brand sale, but the company disputes this and will appeal.
🤖 AI Summary
- GST adjudication order issued 26.03.2026 for FY 2020-21 brand sale transaction
- Demand: Rs. 16,05,41,509 in alleged short-paid CGST/SGST plus applicable interest
- Penalty imposed: Rs. 16,05,41,509, equivalent to tax amount under sections 74 and 122
- Allegation: brand sale treated as mixed supply liable for higher GST rate
- Company position: not accepting demand and filing appeal before appropriate authority
🔢 Key Numbers — exact figures from BSE filing, not rounded
CGST/SGST demanded
Rs. 16,05,41,509
Penalty equivalent to tax
Rs. 16,05,41,509
Total contingent exposure (excl. interest)
Rs. 32,10,83,018
Relevant financial year
FY 2020-21
🏢 How This Affects the Company
Glenmark has disclosed no material impact on financials. However, the contingent liability for Rs. 16,05,41,509 in tax demand plus interest and equal penalty remains unresolved pending appeal outcome.
GST litigation risk on a past transaction creates contingent liability exposure. Outcome of appeal will determine actual financial settlement obligation or reversal of demand.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Monitor quarterly filings and exchange notifications for appeal status updates and any material developments.
👤
Who Is Affected
All shareholders holding Glenmark equity. If appeal is unsuccessful, the company settlement of Rs. 32+ crore (tax plus penalty plus interest) would reduce distributable cash and reported profits.
🔍
Management Signal
Management is contesting the GST demand legally rather than acquiescing, signalling confidence in the transaction's tax treatment or sufficiency of supporting documentation.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Filing of appeal with appellate authority — check for Reg 30 update within 30-60 days
Q4 FY26 financial results — verify no contingent liability reserve disclosed on balance sheet
Appeal outcome communication — material event if demand is upheld or significantly reduced
MEDIUM RISK
Contingent GST liability of Rs. 32+ crore pending appeal outcome. Unfavourable ruling would materially impact cash and earnings; favourable ruling eliminates exposure.
💡 Investor Takeaway
Glenmark received a GST adjudication order on 26 March 2026 demanding Rs. 16,05,41,509 in short-paid tax plus equal penalty on a FY 2020-21 brand sale. Company disputes the demand and will appeal. No material financial impact confirmed at present; appeal resolution timing and outcome remain uncertain.
⚖️ Strengths & Concerns
✅ Positives
- Company explicitly stated no material impact on financials, operations or activities at present.
- Glenmark contesting the demand rather than accepting, indicating factual or legal grounds for challenge.
⚠️ Concerns
- Contingent liability of Rs. 16,05,41,509 in tax demand plus interest and equal penalty remains outstanding.
- GST adjudication order issued; appeal timeline and outcome uncertain, creating extended litigation exposure.